CAGRILINTIDE

---

Cagrilintide is a next-generation amylin analog peptide designed to complement GLP-1 therapies for enhanced appetite and weight control—a hormone that helps regulate appetite, slow gastric emptying, and promote feelings of fullness.

Cagrilintide mimics the natural hormone amylin, which plays a role in:

• Potent appetite suppression
• Enhances fullness and meal satisfaction
• Supports steady, sustained weight loss
• Improves glycemic control and insulin sensitivity
• Synergistic when combined with GLP-1s like TIRZEPATIDE, RETATRUTIDE, and SEMAGLUTIDE

This helps support healthier eating patterns and easier calorie reduction.

✔ Powerful Appetite Control

Helps reduce hunger signals and overeating by enhancing satiety.

✔ Slower Gastric Emptying

Keeps you feeling full longer after meals, reducing cravings and snacking.

✔ Improved Blood Sugar Regulation

Supports more stable glucose levels by slowing carbohydrate absorption and moderating post-meal spikes.

✔ Synergistic With GLP-1 Medications

When combined with GLP-1s like TIRZEPATIDE, RETATRUTIDE, and SEMAGLUTIDE the effect on appetite suppression and weight loss are significantly stronger than either alone.

✔ Once-Weekly Dosing

Convenient injection schedule makes adherence easier.